Who
Stephen Quake
Director
Company insider
Files Form 4 as: Director, AbCellera Biologics; Director, SomaLogic.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Sep 2021
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | ABCL AbCellera Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —111,701 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | ABCL AbCellera Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —111,701 at $0.00 | filing |
| 1 Dec 2025filed 19 Dec 2025 | ABCL AbCellera Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —194,932 at $0.00 | filing |
| 1 Mar 2022filed 3 Mar 2022 | SomaLogicoption or derivative | SEC FORM 4 Code A | —20,600 at $0.00 | filing |
| 1 Mar 2022filed 3 Mar 2022 | SomaLogic | SEC FORM 4 Code A | —3,430 at $0.00 | filing |
| 27 Oct 2021filed 13 Dec 2021 | SomaLogicoption or derivative | SEC FORM 4 Code A | —46,705 at $0.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogicoption or derivative | SEC FORM 4 Code A | —166,666 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogicoption or derivative | SEC FORM 4 Code M | —25,000 at $0.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogic | SEC FORM 4 Code J | —25,000 at $0.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogic | SEC FORM 4 Code A | $1.5M150,000 at $10.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogic | SEC FORM 4 Code A | $1.5M150,000 at $10.00 | filing |
| 1 Sep 2021filed 3 Sep 2021 | SomaLogic | SEC FORM 4 Code A | $1.0M100,000 at $10.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.